Skip to main content

Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis

Clinical Rheumatology volume 38, pages 2873–2880 (2019)Cite this article

Abstract

Introduction

Knee osteoarthritis (OA) is a common form of arthritis in elders which can lead to reduced daily activity and quality of life. It is important to administer a proper treatment with high efficacy and low side effects. In this study, we evaluated the efficacy of duloxetine and gabapentin in patients with moderate to severe knee OA.

Method

In this randomized clinical trial, 150 patients with moderate to severe knee OA were randomly allocated to receive duloxetine 30 mg (n = 50), gabapentin 300 mg (n = 50), or acetaminophen 1000 mg (n = 50) all twice a day for 12 weeks. Pain severity using visual analogue scale (VAS) and functional status using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were measured before, 2 weeks, 1 month, and 3 months after intervention.

Results

WOMAC total and its subscale score were significantly lower in duloxetine compared to gabapentin in 2 weeks and 1 months after intervention, with no significant difference at the end of the third month. Both gabapentin and duloxetine groups had significantly more reduction in pain VAS and WOMAC and its subscales compared to acetaminophen group, with no significant difference between groups.

Conclusions

Both gabapentin and duloxetine have similar and acceptable effects in pain reduction and improvement of functional status in patients with knee OA at the end of the third month’s treatment. Duloxetine effects begin from the first weeks, while gabapentin effects begin gradually with the best at the end of the third month.

Key Points

• Medical treatment is used for releiving pain in knee osteoarthritis.

• Gabapentin and duloxetine are both effective in reducing pain in knee osteoarthritis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Micca JL, Ruff D, Ahl J, Wohlreich MM (2013) Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials. BMC Musculoskelet Disord 2013 14:137

    CAS  Article  Google Scholar 

  2. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM et al (2005) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 13:635–646

    Google Scholar 

  3. Bijlsma JW, Berenbaum F, Lafaber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 18:2115–2126

    Article  Google Scholar 

  4. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM et al (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil 22:363–388

    CAS  Article  Google Scholar 

  5. Woolf CJ (2004) Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140:441–451

    Article  Google Scholar 

  6. Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3–11

    CAS  Article  Google Scholar 

  7. Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF (2005) A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6:346–356

    Article  Google Scholar 

  8. Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67:1411–1420

    CAS  Article  Google Scholar 

  9. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ, Duloxetine Fibromyalgia Trial Group (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974–2984

    CAS  Article  Google Scholar 

  10. Russell JI, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136:432–444

    CAS  Article  Google Scholar 

  11. Skljarevski V, Ossanna MJ, Liu-Seifert H, Zhang Q, Chappell A, Iyengar S, Detke M, Backonja M (2009) A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 16:1041–1048

    CAS  Article  Google Scholar 

  12. Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, Patrick K (2010) Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed dose, randomized, double-blind trial. J Pain 11:1282–1290

    CAS  Article  Google Scholar 

  13. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H (2009) Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 146:253–260

    CAS  Article  Google Scholar 

  14. Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, Brown JP (2011) A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment chronic pain due to osteoarthritis of the knee. Pain Pract 11:33–41

    Article  Google Scholar 

  15. Myers J, Wielage RC, Han B, Price K, Gahn J, Paget MA, Happich M (2014) The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord 15:76

    Article  Google Scholar 

  16. Park J, Yu YP, Zhou CY, Li KW, Wang D, Chang E, Kim DS, Vo B, Zhang X, Gong N, Sharp K, Steward O, Vitko I, Perez-Reyes E, Eroglu C, Barres B, Zaucke F, Feng G, Luo ZD (2016) Central mechanisms mediating thrombospondin-4-induced pain states. J Biol Chem 291:13335–13348

    CAS  Article  Google Scholar 

  17. Pan B, Guo Y, Wu HE, Park J, Trinh VN, Luo ZD, Hogan QH (2016) Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury. Pain 157:2068–2080

    CAS  Article  Google Scholar 

  18. Moore RA, Wiffen PJ, Derry S, McQuay HJ (2011) Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 3:CD007938

    Google Scholar 

  19. Calandre EP, Rico-Villademoros F, Slim M (2016) Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Rev Neurother 16:1263–1277

    CAS  Article  Google Scholar 

  20. Adães S, Ferreira-Gomes J, Mendonça M, Almeida L, Castro-Lopes JM, Neto FL (2015) Injury of primary afferent neurons may contribute to osteoarthritis induced pain: an experimental study using the collagenase model in rats. Osteoarthr Cartil 23:914–924

    Article  Google Scholar 

  21. Gong K, Shao W, Chen H, Wang Z, Luo ZJ (2011) Rat model of lumbar facet joint osteoarthritis associated with facet-mediated mechanical hyperalgesia induced by intra-articular injection of monosodium iodoacetate. J Formos Med Assoc 110:145–152

    CAS  Article  Google Scholar 

  22. Rudroju N, Bansal D, Talakokkula ST, Gudala K, Hota D, Bhansali A et al (2013) Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. Pain Physician 16:E705–E714

    PubMed  Google Scholar 

  23. Arreola Ornelas H, Rosado Buzzo A, García L, Dorantes Aguilar J, Contreras Hernández I, Mould Quevedo JF (2012) Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico. Reumatol Clin 8:120–127

    PubMed  Google Scholar 

  24. Andrews JS, Wu N, Chen SY, Yu X, Peng X, Novick D (2013) Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care. J Pain Res 6:825–835

    Article  Google Scholar 

  25. Nash RJ, Azantsa BK, Sharp H, Shanmugham V (2018) Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial. Clin Interv Aging 13:2119–2126. https://doi.org/10.2147/CIA.S173227

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A, Kolahi B (2015) Efficacy of action potential simulation and interferential therapy in the rehabilitation of patients with knee osteoarthritis. Ther Adv Musculoskelet Dis 7:67–75

    Article  Google Scholar 

  27. Nadrian H, Moghimi N, Nadrian E, Moradzadeh R, Bahmanpour K, Iranpour A, Bellamy N (2012) Validity and reliability of the Persian versions of WOMAC Osteoarthritis Index and Lequesne Algofunctional Index. Clin Rheumatol 31:1097–1102

    Article  Google Scholar 

  28. Mora JC, Przkora R, Cruz-Almeida Y (2018) Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res 11:2189–2196

    CAS  Article  Google Scholar 

  29. Jevsevar DS (2013) Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 21:571–576

    PubMed  Google Scholar 

  30. Bindawas SM, Vennu V, Al Snih S (2015) Differences in health-related quality of life among subjects with frequent bilateral or unilateral knee pain: data from the Osteoarthritis Initiative study. J Orthop Sports Phys Ther 45:128–136

    Article  Google Scholar 

  31. Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A (2015) The efficacy of 100 and 300 mg gabapentin in the treatment of carpal tunnel syndrome. Iran J Pharm Res 14:1275–1280

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, He D, Wang CN, Dueñas H, Skljarevski V, Yue L (2017) Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study. Osteoarthr Cartil 25:832–838

    CAS  Article  Google Scholar 

  33. Vonsy JL, Ghandehari J, Dickenson AH (2009) Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain 13:786–793

    CAS  Article  Google Scholar 

  34. Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S (2018) A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res 11:809–821

    CAS  Article  Google Scholar 

  35. Wang ZY, Shi SY, Li SJ, Chen F, Chen H, Lin HZ, Lin JM (2015) Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med 16:1373–1385

    Article  Google Scholar 

  36. Sofat N, Harrison A, Russell MD, Ayis S, Kiely PD, Baker EH, Barrick T, Howe F (2017) The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis. J Pain Res 10:2437–2449

    CAS  Article  Google Scholar 

  37. Wiffen PJ, Derry S, Bell RF, Rice AS, Tölle TR, Phillips T et al (2017) Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 6:CD007938

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

    Afsaneh Enteshari-Moghaddam, Ahad Azami, Hamed Mohebbi & Afshin Habibzadeh

  2. Social Determinants of Health Research Center (SDH), Ardabil University of Medical Sciences, Ardabil, Iran

    Khatereh Isazadehfar

  3. Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, 5618985991, Iran

    Hamed Mohebbi

  4. Nuclear Medicine Research Center, School of Medicine, Mashahd University of Medical Sciences, Mashahd, Iran

    Parinaz Jahanpanah

Authors
  1. Afsaneh Enteshari-Moghaddam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahad Azami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khatereh Isazadehfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hamed Mohebbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Afshin Habibzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parinaz Jahanpanah
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All the authors edited and critically reviewed the manuscript drafts and approved the final version submitted for publication. AEM was the principal investigator, performed a literature search, and was involved in the study design, collection, analysis, and interpretation of data and in writing the manuscript. AH and PJ were involved in the collection and interpretation of data and writing the manuscript. KI contributed to the conception and design of the study, the data interpretation, and the critical revision of the manuscript. HM was involved in collection and interpretation of data, performed a literature search, and in writing the manuscript.

Corresponding author

Correspondence to Hamed Mohebbi.

Ethics declarations

Disclosures

None.

Patient consent

Obtained

Ethics approval

The study was conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines and with local requirements.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Enteshari-Moghaddam, A., Azami, A., Isazadehfar, K. et al. Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis. Clin Rheumatol 38, 2873–2880 (2019). https://doi.org/10.1007/s10067-019-04573-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04573-7

Keywords

  • Duloxetine
  • Gabapentin
  • Knee osteoarthritis
  • Pain